U.S. Markets open in 3 hrs 58 mins

See what the IHS Markit Score report has to say about Cigna Corp.

IHS Markit

Cigna Corp

NYSE:CI

Score: Neutral (47)

42 days at current score.

Downgraded from Positive on August 8th 2018

View full report here!

Summary


  • This company ranked neutral compared to the Healthcare sector with only 2 positive IHS Markit Categories
  • Perception of the company's creditworthiness is neutral
  • Bearish sentiment is low
  • Economic output in this company's sector is expanding


Bearish sentiment

Short interest | Positive

Short interest is extremely low for CI with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CI.

Money flow

ETF/Index ownership | Neutral

ETF activity is neutral. The net inflows of $6.71 billion over the last one-month into ETFs that hold CI are not among the highest of the last year and have been slowing.

Economic sentiment

PMI by IHS Markit | Positive

According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year.

Credit worthiness

Credit default swap | Neutral

The current level displays a neutral indicator. Although CI credit default swap spreads are decreasing, they remain near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.

Please send all inquiries related to the report to score@ihsmarkit.com.

Charts and report PDFs will only be available for 30 days after publishing.

This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.